300832 ShenZhen New Industries Biomedical Engineering
- 62.88
- +0.30+0.48%
ShenZhen New Industries Biomedical Engineering News
Shenzhen New Industries Biomedical Engineering Gets Nod to Register Antiphospholipid Assay Kit
Shenzhen New Industries Biomedical Engineering (stock code: 300832.SZ) announced that the "Anti-Cardiolipin IgA Test Kit (chemiluminescence microparticle immunoassay)" has obtained the registration certificate of medical instruments.
On August 14th, Gelunhui reported that Shenzhen New Industries Biomedical Engineering Co., Ltd., a subsidiary of New Industry (300832.SZ), recently received a "Medical Device Registration Certificate" from the Guangdong Provincial Drug Administration for the Anti-Phospholipid Antibody IgA Detection Kit (Chemiluminescence Magnetic Microparticle Method).
Could The Market Be Wrong About Shenzhen New Industries Biomedical Engineering Co., Ltd. (SZSE:300832) Given Its Attractive Financial Prospects?
Shenzhen New Industries Biomedical Engineering (300832.SZ) has received one medical instrument registration certificate.
On August 2nd, Gelon Hui reported that Shenzhen New Industries Biomedical Engineering Co., Ltd. in Guangdong recently received a "Medical Device Registration Certificate" issued by the Guangdong Provincial Drug Administration for the Anti-β2 Glycoprotein 1 Antibody Detection Reagent Kit (Chemiluminescent Microparticle Immunoassay).
Shenzhen new industries biomedical engineering (stock code: 300832.SZ) has obtained two medical instrument registration certificates.
On July 31st, Gelunhui reported that Shenzhen New Industries Biomedical Engineering Co., Ltd. (hereinafter referred to as the "company") has recently received two Medical Device Registration Certificates issued by the Guangdong Provincial Food and Drug Administration. They are anti-beta2-glycoprotein 1 antibody IgA detection reagent kit (magnetic chemiluminescence method) and prealbumin detection reagent kit (immune transmission turbidity method).
Shenzhen New Industries Biomedical Engineering (300832.SZ) has obtained three medical instrument registration certificates.
Shenzhen New Industries Biomedical Engineering (300832.SZ) announced on July 26th that it has recently received two "Medical Instrument Registration Certificates" from the National Medical Products Administration and one from the Guangdong Provincial Medical Products Administration. The products include chemiluminescence immunoassay kits for detecting IgM antibodies to the type A influenza virus, chemiluminescence immunoassay kits for detecting IgM antibodies to the Coxsackie virus group B, and reagents for detecting anticardiolipin antibodies using magnetic micro-particle chemiluminescence technology.
Shenzhen New Industries Biomedical Engineering (stock code: 300832.SZ) has obtained 4 invention patent certificates.
On July 25th, Gelonhui reported that Shenzhen New Industries Biomedical Engineering (300832.SZ) recently received four "Invention Patent Certificates" from the Russian Federal Intellectual Property Bureau. They are amplification plate components and their status detection method, sample analysis equipment, target material processing device and nucleic acid detection integrated machine with it, and amplification detection device and carrying method for amplification detection.
We Ran A Stock Scan For Earnings Growth And Shenzhen New Industries Biomedical Engineering (SZSE:300832) Passed With Ease
Nomura Adjusts Shenzhen New Industries Biomedical Engineering's Price Target to 95.86 Yuan From 93.36 Yuan, Keeps at Buy
Shenzhen New Industries Biomedical Engineering Co., Ltd.'s (SZSE:300832) Share Price Could Signal Some Risk
Shenzhen New Industries Biomedical Engineering (300832.SZ) has received two registrations for medical instruments.
On July 5th, Gelonhui reported that Shenzhen New Industries Biomedical Engineering Co., Ltd. received two Medical Instrument Registration Certificates issued by the Guangdong Provincial Drug Administration recently.
The joint venture battery factory between Hyundai Motor and LG new energy in Indonesia has been completed.
Hyundai Motor Group announced on Wednesday that the Indonesian electric vehicle battery factory jointly built with LG New Energy (LGES) has been completed. With this, Hyundai Motor Group has a fully integrated electric vehicle production system in Indonesia. Hyundai Motor Group stated that the completion ceremony of the Hyundai LG Indonesia Dynagreen Environmental Protection Group (HLI Green Power) battery factory was held in Karawang New Industry City, the manufacturing center in East Jakarta, Indonesia. Hyundai said that from this month, batteries produced by HLI Green Power will be used in independent auto manufacturing plants in Indonesia on a large scale.
Shenzhen New Industries Biomedical Engineering (300832.SZ) obtained a medical instrument registration certificate.
Shenzhen New Industries Biomedical Engineering (Stock Code: 300832.SZ) announced that the company has received one Medical Device Manufacturing License from Guangdong Medical Products Administration.
Shenzhen New Industries Biomedical Engineering (SZSE:300832) Might Be Having Difficulty Using Its Capital Effectively
Shenzhen New Industries Biomedical Engineering Gets Registration Certificate for Detection Kit
Shenzhen New Industries Biomedical Engineering (300832.SZ) has acquired a medical instrument registration certificate.
Shenzhen New Industries Biomedical Engineering (Stock Code: 300832.SZ) announced that the company has received one Medical Device Manufacturing License from Guangdong Medical Products Administration.
New industry (300832.SZ): 190 products obtained IVDR CE certification
Gelonghui, May 27丨New Industry (300832.SZ) announced that recently, 190 products of Shenzhen New Industry Biomedical Engineering Co., Ltd. obtained IVDR CE certification issued by TÜV SÜD, the EU Notified Body, including 16 chemiluminescence reagents, 16 chemiluminescence quality control products, 57 biochemical reagents, 41 biochemical quality control products, and 60 biochemical calibration products. Among them, the hepatitis C virus antibody test kit (chemiluminescence immunoassay) obtained IVDRCE's highest risk level ClassD certification.
New industry (300832.SZ): Shareholders and directors agree to reduce their holdings by no more than 483,400 shares in total
Gelonghui, May 13 | New Industry (300832.SZ) announced that the company recently received a “Notice Letter on the Share Reduction Plan” issued by Ms. Xu Dinghong, a shareholder and director of the company who holds more than 5% of the company's shares, and Ms. Liu Haiyan, senior management of the company, and Ms. Zhang Lei. Xu Dinghong, Liu Haiyan, and Zhang Lei held 103,360 shares, 1,139,700 shares, and 3,341,500 shares of the company's total share capital respectively (accounting for 0.0132%, 01451%, and 0.4253% of the company's total share capital, respectively), and are scheduled for 15 trading days from the date of the announcement of the reduction plan
There's A Lot To Like About Shenzhen New Industries Biomedical Engineering's (SZSE:300832) Upcoming CN¥1.00 Dividend
New Industries (300832.SZ) plans to pay $10 for every 10 shares in 2023, excluding interest on May 15
New Industry (300832.SZ) announced that the company plans to pay 10.00 for every 10 shares to all shareholders in 2023...
Analysis
Price Target
No Data
